Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATAPEMBRO: Pembrolizumab Combined With Ataluren in Metastatic Colorectal and Endometrial Cancer
NCT04014530Phase 2Unknown
- Sponsor
- University of Amsterdam
- Start
- Aug 2019
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ataluren in colorectal cancer (CRC), endometrial cancer (EC), sponsored by University of Amsterdam. Status: unknown.
02
Drugs
ataluren
03
Conditions
colorectal cancer (CRC)endometrial cancer (EC)
Beyond the preview
Go deeper on NCT04014530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04014530.